Jeffrey Wade
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Jeffrey Wade
Jeffrey Wade is recorded as CFO at Lexicon Pharmaceuticals, Inc. (LXRX). The proxy statement of Lexicon Pharmaceuticals, Inc. reports total compensation of $2,564,274 for Jeffrey Wade in fiscal 2024, including a base salary of $485,525. Disclosed compensation is on record for 8 fiscal years. Jeffrey Wade has spoken on 4 earnings calls across 1 company, most recently for Lexicon Pharmaceuticals, Inc. on May 2, 2024.
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Lexicon Pharmaceuticals, Inc.
Other people whose current roles at this company are on record from its filings.
- Michael Exton, Ph.D. CEO, Board Member
- Michael S. Exton CEO, Board Member
- Raymond Debbane Chairman
- Kristen L. Alexander CFO, Chief Accounting Officer
- Jeffrey L. Wade COO
- Christopher J. Sobecki Board Member
- Diane E. Sullivan Board Member
- Ivan H. Cheung Board Member
- Judith L. Swain Board Member
- Philippe J. Amouyal Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2024 | Lexicon Pharmaceuticals, Inc. (LXRX) | Former President and Chief Financial Officer | $485,525 | $2,564,274 |
| 2023 | Lexicon Pharmaceuticals, Inc. (LXRX) | Former President and Chief Financial Officer | $535,729 | $1,962,868 |
| 2022 | Lexicon Pharmaceuticals, Inc. (LXRX) | Former President and Chief Financial Officer | $513,354 | $1,990,163 |
| 2021 | Lexicon Pharmaceuticals, Inc. (LXRX) | President and Chief Financial Officer | $476,319 | $1,651,683 |
| 2020 | Lexicon Pharmaceuticals, Inc. (LXRX) | President and Chief Financial Officer | $456,372 | $1,629,502 |
| 2019 | Lexicon Pharmaceuticals, Inc. (LXRX) | President and Chief Financial Officer | $444,431 | $1,614,323 |
| 2018 | Lexicon Pharmaceuticals, Inc. (LXRX) | Executive Vice President, Corporate and Administrative Affairs and Chief Financial Officer | $436,644 | $1,408,003 |
| 2017 | Lexicon Pharmaceuticals, Inc. (LXRX) | Executive Vice President, Corporate and Administrative Affairs and Chief Financial Officer | $427,038 | $1,214,435 |
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.